Logo image of CABKA.AS

CABKA (CABKA.AS) Stock Fundamental Analysis

AMS:CABKA - Euronext Amsterdam - NL00150000S7 - Common Stock - Currency: EUR

1.95  -0.05 (-2.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CABKA. CABKA was compared to 15 industry peers in the Containers & Packaging industry. CABKA may be in some trouble as it scores bad on both profitability and health. CABKA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CABKA has reported negative net income.
CABKA had a positive operating cash flow in the past year.
In the past 5 years CABKA reported 4 times negative net income.
Each year in the past 5 years CABKA had a positive operating cash flow.
CABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFCABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CABKA's Return On Assets of -5.39% is on the low side compared to the rest of the industry. CABKA is outperformed by 80.00% of its industry peers.
CABKA has a Return On Equity of -16.49%. This is amonst the worse of the industry: CABKA underperforms 86.67% of its industry peers.
With a Return On Invested Capital value of 0.11%, CABKA is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.39%
ROE -16.49%
ROIC 0.11%
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
CABKA.AS Yearly ROA, ROE, ROICCABKA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CABKA's Operating Margin of 0.07% is on the low side compared to the rest of the industry. CABKA is outperformed by 80.00% of its industry peers.
In the last couple of years the Operating Margin of CABKA has declined.
CABKA has a better Gross Margin (49.83%) than 73.33% of its industry peers.
CABKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.07%
PM (TTM) N/A
GM 49.83%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
CABKA.AS Yearly Profit, Operating, Gross MarginsCABKA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CABKA is destroying value.
CABKA has about the same amout of shares outstanding than it did 1 year ago.
CABKA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CABKA is higher compared to a year ago.
CABKA.AS Yearly Shares OutstandingCABKA.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CABKA.AS Yearly Total Debt VS Total AssetsCABKA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that CABKA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CABKA (1.28) is worse than 73.33% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that CABKA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, CABKA is in line with its industry, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.02
WACC6.39%
CABKA.AS Yearly LT Debt VS Equity VS FCFCABKA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CABKA has a Current Ratio of 0.90. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.90, CABKA is doing worse than 73.33% of the companies in the same industry.
A Quick Ratio of 0.43 indicates that CABKA may have some problems paying its short term obligations.
The Quick ratio of CABKA (0.43) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.43
CABKA.AS Yearly Current Assets VS Current LiabilitesCABKA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CABKA have decreased strongly by -505.76% in the last year.
Looking at the last year, CABKA shows a decrease in Revenue. The Revenue has decreased by -7.63% in the last year.
CABKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.52% yearly.
EPS 1Y (TTM)-505.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.06%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-3.26%

3.2 Future

The Earnings Per Share is expected to grow by 55.85% on average over the next years. This is a very strong growth
CABKA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.66% yearly.
EPS Next Y138.1%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
EPS Next 5Y55.85%
Revenue Next Year3.41%
Revenue Next 2Y5.42%
Revenue Next 3Y6.72%
Revenue Next 5Y4.66%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CABKA.AS Yearly Revenue VS EstimatesCABKA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
CABKA.AS Yearly EPS VS EstimatesCABKA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3 0.4 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CABKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 94.66, the valuation of CABKA can be described as expensive.
73.33% of the companies in the same industry are cheaper than CABKA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CABKA to the average of the S&P500 Index (22.17), we can say CABKA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 94.66
CABKA.AS Price Earnings VS Forward Price EarningsCABKA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CABKA indicates a somewhat cheap valuation: CABKA is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.55
CABKA.AS Per share dataCABKA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CABKA's earnings are expected to grow with 93.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.6%
EPS Next 3Y93.15%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.54%, CABKA is a good candidate for dividend investing.
CABKA's Dividend Yield is rather good when compared to the industry average which is at 4.25. CABKA pays more dividend than 100.00% of the companies in the same industry.
CABKA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.54%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CABKA are negative and hence is the payout ratio. CABKA will probably not be able to sustain this dividend level.
DP-39.63%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
CABKA.AS Yearly Income VS Free CF VS DividendCABKA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

More info and screens

CABKA

AMS:CABKA (6/2/2025, 7:00:00 PM)

1.95

-0.05 (-2.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.31%
Ins Owner ChangeN/A
Market Cap79.36M
Analysts85.45
Price Target4.15 (112.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.54%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP-39.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.27%
PT rev (3m)-15.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-77.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-3.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 94.66
P/S 0.44
P/FCF N/A
P/OCF 4.83
P/B 1.4
P/tB 1.47
EV/EBITDA 7.55
EPS(TTM)-0.38
EYN/A
EPS(NY)0.02
Fwd EY1.06%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.4
OCFY20.72%
SpS4.47
BVpS1.39
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.39%
ROE -16.49%
ROCE 0.14%
ROIC 0.11%
ROICexc 0.11%
ROICexgc 0.11%
OM 0.07%
PM (TTM) N/A
GM 49.83%
FCFM N/A
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-70.71%
ROICexcg growth 5Y-54.98%
ROICexc growth 3Y-70.91%
ROICexc growth 5Y-54.99%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 1.92
Cap/Depr 92.89%
Cap/Sales 10.3%
Interest Coverage 0.03
Cash Conversion 80.98%
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.43
Altman-Z 1.28
F-Score4
WACC6.39%
ROIC/WACC0.02
Cap/Depr(3y)138.03%
Cap/Depr(5y)116.14%
Cap/Sales(3y)12.71%
Cap/Sales(5y)11.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-505.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.06%
EPS Next Y138.1%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
EPS Next 5Y55.85%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-3.26%
Revenue Next Year3.41%
Revenue Next 2Y5.42%
Revenue Next 3Y6.72%
Revenue Next 5Y4.66%
EBIT growth 1Y-95.24%
EBIT growth 3Y-68.28%
EBIT growth 5Y-53%
EBIT Next Year740.29%
EBIT Next 3Y131.17%
EBIT Next 5Y67.76%
FCF growth 1Y48.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.52%
OCF growth 3Y-9.12%
OCF growth 5Y-4.78%